Date Name Title Filing Type Shares Traded Price Total Held
Jan 05, 2005
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) 263,000 -- --
Sep 17, 2003
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 5,000 -- --
Sep 17, 2003
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 34,250 -- --
Sep 17, 2003
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 87,060 -- --
Apr 09, 2007
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 456 -- 100
Dec 27, 2005
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 1,100 -- 101
Apr 09, 2007
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 300 -- 556
Jan 03, 2007
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 2,900 -- 600
Dec 19, 2017
Director, President and CSO
Director, President and CSO Form 4 Bona fide gift 242,150 -- 847
Apr 09, 2007
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 2,120 -- 856

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.